Primary Headache Disorders: Focus on Migraine

Abstract

•

Migraine is the most common disabling headache disorder.

•

Most patients with disabling tension-type headache are likely to have migraine and accordingly respond to treatments efficacious in migraine.

•

Individuals are genetically predisposed to experiencing recurrent migraine.

•

Evidence supports migraine to be a primarily neural and not vascular mediated disorder.

•

1–2% of the population have chronic daily headache associated with acute-relief medication overuse; the majority are migraineurs.

•

The presence of acute-relief medication overuse renders preventative medication less adequately efficacious.

Keywords

migraine aura headache primary headache disorders disabling tension-type headache medication overuse headache

Get full access to this article

View all access options for this article.

References

Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders (II). Cephalalgia 2004;24(Suppl 1):1–160.

Leonardi

Steiner

Scher

Lipton

The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache and Pain 2005;6:429–40.

Steiner

Scher

Stewart

Kolodner

Liberman

Lipton

The prevalence and disability burden of adult migraine in England and their relationship to age, gender and ethnicity. Cephalalgia 2003;23(7):519–27.

Lipton

Stewart

The epidemiology of migraine. Eur Neurol 1994;34(S2):6–11.

Scher

Stewart

Liberman

Prevalence of frequent headache in a population sample. Headache 1998;38(7):497–506.

Castillo

Muñoz

Guitera

Pascual

Epidemiology of chronic daily headache in the general population. Headache 1999;39(3):190–6.

Wang

Fuh

Liu

Hsu

Chronic daily headache in Chinese elderly: prevalence, risk factors and biannual follow-up. Neurology 2000;54(2):3l4–9.

S-R

Fuh

J-L

Chen

W-T

Juang

K-D

Wang

S-J

Chronic daily headache in Tapei, Taiwan: Prevalence, follow-up and outcome predictors. Cephalalgia 2001;21(10):980–6.

Blau

Adult migraine: The patient observed. In: Blau

, ed. Migraine: clinical, therapeutic, conceptual and research aspects. London: Chapman and Hall 1987:3–30.

10.

Russell

Andersson

Iselius

Cluster headache is an inherited disorder in some families. Headache 1996;36(10):608–12.

11.

Giffin

Ruggiero

Lipton

Silberstein

Tvedskov

Premonitory symptoms in migraine: An electronic diary study. Neurology 2003;60(6):935–40.

12.

Rasmussen

Jensen

Olesen

A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia 1991;11(3):129–34.

13.

Kelman

Migraine pain location: A tertiary care study of 1283 migraineurs. Headache 2005;45(8):1038–47.

14.

Chakravaty

Mukhurjee

Roy

Migraine pain location in adult patients from eastern India. Annals Indian Acad of Neurol 2008;11(2):98–102.

15.

Kaube

Keay

Hoskin

Bandler

Goadsby

Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 1993;629(1):95–102.

16.

Busch

Jakob

Juergens

Schulte-Mattler

Kaube

May

Occipital nerve blockade in chronic cluster headache patients and functional connectivity between trigeminal and occipital nerves. Cephalalgia 2007;27(11):1206–14.

17.

Afridi

Shields

Bhola

Goadsby

Greater occipital nerve injections in primary headache syndromes — prolonged effects from a single injection. Pain 2006;122(1–2):126–9.

18.

Saper

Dodick

Silberstein

McCarville

Sun

Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 2010;31(3):271–85.

19.

Couch

Diamond

Status migrainosus: Causative and therapeutic aspects. Headache. 1983;23(3):94–101.

20.

Celentano

Stewart

Linet

The relationship of headache symptoms with severity and duration of attacks. J Clin Epidem 1990;43(9):983–4.

21.

Prensky

Migraine in children. In: Blau

, ed. Migraine: Clinical, therapeutic, conceptual and research aspects. London: Chapman and Hall 1987:31–54.

22.

Blau

Resolution of migraine attacks: sleep and recovery phase. J Neurol Neurosurg Psych 1982;45(3):223–6.

23.

Bahra

May

Goadsby

Cluster headache: A prospective clinical study with diagnostic implications. Neurology 2002;58(3):354–61.

24.

Peres

MFP

Siow

Rozen

Hemicrania continua with aura. Cephalagia 2002;22(3):246–8.

25.

Matharu

Goadsby

Post-traumatic paroxysmal hemicrania. Neurology 2001;56(2):273–5.

26.

Russell

Olesen

A nosographic analysis of the migraine aura in a general population. Brain 1996;119(2):335–61.

27.

Eriksen

Thomsen

Andersen

Nazim

Olesen

Clinical characteristics of 362 patients with familial migraine with aura. Cephalalgia 2004;24(7):564–75.

28.

Blau

Classic migraine: symptoms between visual aura and headache onset. Lancet 1992;340(8815):355–6.

29.

Thomsen

Eriksen

Roemer

Andersen

Olesen

Russell

A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 2002;125:1379–91.

30.

Lipton

Cady

Stewart

Wilks

Hall

Diagnostic lessons from the Spectrum Study. Neurology 2002;58(Suppl 6):S27–S31.

31.

Ashina

Bendtsen

Jensen

Schifter

Jansen-Olesen

Olesen

Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 2000;55(9):1335–9.

32.

Cady

Gutterman

Saiers

Beach

Responsiveness of non-IHS migraine and tension-type headache. Cephalalgia 1997;17(5):588–90.

33.

Wolff

, ed. Headache and other head pain. New York: Oxford University Press 1963.

34.

Martins

Baeta

Paiva

Campo

Gomes

. Headaches during intracranial endovascular procedures: a possible model of vascular headache. Headache 1993;33(5):227–33.

35.

Graham

Wolff

Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psych 1938;39(4Orofacial Pain: Part Two):737–63.

36.

Drummond

Lance

Neurovascular disturbances in headache patients. Clin Exp Neurol 1984;20:93–9.

37.

Rahmann

Wienecke

Hansen

Fahrenkrug

Olesen

Ashina

Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 2008;28(3):226–36.

38.

Matharu

Goadbsy

Persistence of attacks of cluster headache after trigeminal root section. Brain 2002;125(5):976–84.

39.

Humphrey

Feniuk

Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 1991;12(12):444–6.

40.

Hoskin

Kaube

Goadsby

Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain 1996;119(Pt 1):249–56.

41.

Bartsch

Knight

Goadsby

Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol 2004;56(3):371–81.

42.

Weiller

May

Limmroth

Juptner

Kaube

Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;1(7):658–60.

43.

May

Bahra

Buchel

Frackowiak

RSJ

Goadsby

Hypothalamic activation in cluster headache attacks. Lancet 1998;352(9124):275–8.

44.

van den Maagdenberg

Haan

Terwindt

Ferrari

Migraine: gene mutations and functional consequences. Curr Opin Neurol 2007;20(3):299–305.

45.

Lafrenière

Cader

Poulin

Andres-Enguix

Simoneau

Gupta

A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med. 2010;16(10):1157–60.

46.

Robbins

Precipitating factors in migraine: A restrospective review of 494 patients. Headache 1994;34(4Orofacial Pain: Part Two):214–6.

47.

Van den Bergh

Amery

Waelkens

Trigger factors in migraine: A study conducted by the Belgian Migraine Society. Headache 1987;27(4Orofacial Pain: Part Two):191–6.

48.

Turner

Molgaard

Gardner

Rothcock

Stang

Migraine trigger factors in a non-clinical Mexican-American population in San Diego county: implications for etiology. Cephalalgia 1995;15(6):523–30.

49.

McQueen

Loblay

A controlled trial of dietary modification in migraine. In: Rose

, ed. New Advances in Headache Research. London: Smith Gordon 1989.

50.

Limmroth

Katsarava

Fritsche

Przywara

Diener

Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59(7):1011–4.

51.

Silverman

Evans

Strain

Withdrawal syndrome after double-blind cessation of caffeine consumption. New Eng J Med 1992;327(16):1109.

52.

Silberstein

Merriam

Sex hormones and headache. In: Goadsby

Silberstein

, eds. Headache. Woburn, MA: Butterworth-Heinemann 1997:143–73.

53.

Evers

S AJ

Frese

Goadsby

Linde

May

Sandor

EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol 2006;13(6):560–72.

54.

Ferrari

Goadbsy

Roon

Lipton

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalagia 2002;22:633–58.

55.

Brandes

Kudrow

Stark

O'Carroll

Adelman

Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007;297(13):1443–54.

56.

The Subcutaneous Sumatriptan International Study Group. Treatment of acute migraine with sumatriptan. New Eng J Med 1991;325(5):316–21.

57.

Tfelt-Hansen

Rolan

Non-steroidal anti-inflammatory drugs in the acute treatment of migraines. In: Olesen

Goadbsy

Ramadan

eds. The headaches. 3rd ed. Philadelphia: Lippincott Williams and Wilkins 2006.

58.

Lipton

Stewart

Stone

Stratified care vs step care startegies for migraine: results of the Disability in Strategies of Care (DISC) Study. JAMA 2000;284(20):754–63.

59.

Valade

Early treatment of acute migraine: new evidence of benefits. Cephalalgia 2009;Suppl 3.

60.

Linde

Melberg

Dahlof

Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack. Cephalalgia 2006;26(2):113–21.

61.

Saper

Ergotamine dependancy - a review. Headache 1987;27(8):435–8.

62.

Bates

Ashford

Dawson

Ensink

F-BM

Gilhus

Subcutaneous sumatriptan during migraine aura. Neurology 1994;44(9):1587–92.

63.

Thomsen

Dixon

Lassen

Giboens

Langemark

311C90 (Zolmitriptan), a novel centrally and peripheral acting oral 5-hydroxytryptamine-1D agonist: a comparison of its absorption during a migraine attacks and in a migraine-free period. Cephalalgia 1996;16(4Orofacial Pain: Part Two):270–5.

64.

Tokola

Kangasniemi

Neuvonen

Tokola

Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks. Cephalalgia 1983;4(4Orofacial Pain: Part Two):253–63.

65.

MacGregor

Wilkinson

Bancroft

Domperidone plus paracetamol in the treatment of migraine. Cephalalgia 1993;13(2):124–7.

66.

Bahra

Walsh

Menon

Goadsby

Does chronic daily headache arise de novo in association with regular analgesic use?

Headache 2003;43(3):179–90.

67.

Paemeleire

Bahra

Evers

Matharu

Goadbsy

Medication-overuse headache in patients with cluster headache. Neurology 2006;67(1):109–13.

68.

Diener

H-C

Dichgans

Scholz

Geiselhart

Gerber

W-G

Bille

Analgesic-induced chronic headache: long term results of withdrawal therapy. J Neurol 1989;236(1):9–14.

69.

Zeeberg

Olesen

Jensen

Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006;26(10):1192–8.

70.

Evers

Marziniak

Clinical features, pathophysiology and treatment of medication-overuse headache. Lancet Neurol 2010; (4Orofacial Pain: Part Two):391–401.

71.

Bigal

Lipton

Modifiable risk factors for migraine progression (or for chronic daily headaches) - clinical lessons. Headache 2006;46(Suppl 3):S144–6.

72.

Radat

Swendsen

Psychiatric comorbidity in migraine: a review. Cephalalgia 2004;25(3):165–78.

73.

Alter

Daube

Franklin

Frishberg

Goldstein

Practice parameter: The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994;44(7):1353–4.

74.

Weiss

Stern

Goldberg

Post-traumatic migraine: chronic migraine precipitated by minor head or neck trauma. Headache 1991;31(7):451–6.

75.

Rosenberg

Silberstein

The headache of SAH responds to sumatriptan. Headache 2005;45(5):597–8.

76.

Vestergaard

Andersen

Nielsen

Jensen

Headache in stroke. Stroke 1993;24(11):1621–4.

77.

Slooter

Ramos

Kappelle

Migraine-like headache as the presenting symptom of cerebral venous sinus thrombosis. J Neurol 2002;249(6):775–6.

78.

Lampl

Yazdi

Buzath

Klingler

Migraine-like headache in bacterial meningitis. Cephalalgia 2000;20(8):738–9.

79.

Scelsa

Lipton

Sander

Herskovitz

Headache characteristics in hospitalized patients with Lyme disease. Headache 1995;35(3):125–30.